As a trusted leader in the immunotherapy field, the Society for Immunotherapy of Cancer (SITC) collaborates with other groups to contribute toward high-quality educational programming on tumor immunology and cancer immunotherapy.
Through these educational partnerships, SITC is able to bring high quality, timely cancer immunotherapy information to learners around the world from a variety of backgrounds including scientists, academicians, researchers, clinicians, government representatives and industry leaders.
SITC offers various levels of support for the programs below, such as sharing information about unique programs, providing expert speakers to enhance programming and organizing immunotherapy sessions at relevant association meetings.
If you'd like to get in touch with the society to discuss Collaborative Education Programs, please email the SITC Education Department at firstname.lastname@example.org.
Cancer rates across the Middle East are expected to double between 2012 and 2030, according to World Health Organization (WHO) estimates-the highest relative increase of any region globally. This rise is caused by a combination of environmental ...
The cited editorial states that even with modest survival benefits, tripling of PFS as related to the PACIFIC trial of use of durvalumab immediately after chemoradiotherapy is commendable. Given minimal side effects, its addition should be considered ...
Dear Colleagues ,
Sidra Medicine is proud to host Qatar's first International Workshop on Engineered Immune Cells in Cancer Immunotherapy (EICCI): from Discovery to "Off-the shelf" Development.
Translating the potency of the anti-cancer immune ...
Dear Colleagues ,
It is our distinct pleasure to invite you to attend the Global Conference on Cancer & Oncology Research taking place at Dubai, UAE.
Date: Monday 04 and Tuesday 05 March 2019
Venue: Radisson Blu Hotel, Dubai Waterfront ...
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com